Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Small reprieve for German high-risk products, but is it enough?

This article was originally published in Clinica

Executive Summary

The latest chapter in the passage into law of Germany’s sickness insurance healthcare provision (GKV-VSG) draft is upon us. Today (11 June), the second and third readings were to be held (as agenda point 6) in the lower house. MPs were to hear draft law 18/4095 in its latest form, ie reflecting recent budget committee decisions and those of the 14th sitting of the health committee.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT102663

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel